Medical treatment of hidradenitis suppurativa

Expert Opinion on Pharmacotherapy

Volumn 5, Issue 8, 2004, Pages 1767-1770

  Jemec, Gregor B E ^a  

^a ROSKILDE HOSPITAL   (Denmark)

Author keywords

Antiandrogens; Clindamycin; Hidradenitis suppurativa; Immunosupressants; Infliximab; Quality of life; Retinoids; Skin disease; Systemic therapy; Tetracycline; Topical therapy

Indexed keywords

ANTIANDROGEN; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN; CYPROTERONE ACETATE; CYTOKINE; DAPSONE; ESTROGEN; ETANERCEPT; ETRETIN; ETRETINATE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; MONOCLONAL ANTIBODY; ORAL CONTRACEPTIVE AGENT; PLACEBO; STEROID; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ACNE VULGARIS; AXILLA; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MECHANISM; HIRSUTISM; HUMAN; HYPERANDROGENISM; INGUINAL REGION; LOW LEVEL LASER THERAPY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; REVIEW; SKIN DISEASE; STAPHYLOCOCCUS AUREUS; SUPPURATIVE HIDRADENITIS; SURGICAL TECHNIQUE;

ACNE VULGARIS; ANDROGEN ANTAGONISTS; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; HIDRADENITIS SUPPURATIVA; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 4344630792     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.5.8.1767     Document Type: Review

References (28)

1. JEMEC GBE: Hidradenitis suppurativa. J. Cutan Med Surg. (2003) 7(1):47-56.
2. VON DER WERTH JM, JEMEC GBE: Morbidity in patients with hidradenitis suppurativa. Br. J. Dermatol. (2001) 144(4):809-813.
3. VON DER WERTH JM, WILLIAMS HC: The natural history of hidradenitis suppurativa. J. Eur. Acad. Dermatol. Venereol. (2000) 14(5):389-392.
4. JEMEC GBE, WENDELBOE P: Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J. Am. Acad. Dermatol. (1998) 39(6):971-974.
5. JEMEC GBE, THOMSEN BM, HANSEN U: The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS (1997) 105(5):378-383.
6. + keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp. Dermatol. 13(6):361-363.
7. ROMPEL R, PETRES J: Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol. Surg. (2000) 26(7):638-643.
8. LAPINS J, SARTORIUS K, EMTESTAM L: Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J. Am. Acad. Dermatol. (2002) 47(2):280-285.
9. GOLD M, BRIDGES TM, BRADSHAW VL, BORING M: ALA-PDT and blue light therapy for hidradenitis suppurativa. J. Drugs Dermatol. (2004) 3(1 Suppl.):S32-S35.
10. LAPINS J, JARSTRAND C, EMTESTAM L: Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br. J. Dermatol. (1999) 140(1):90-95.
11. JEMEC GBE, FABER M, GUTSCHIK E, WENDELBOE P: The bacteriology of hidradenitis suppurativa. Dermatology (1996) 193(3):203-206.
12. CLEMMENSEN OJ: Topical treatment of hidradenitis suppurativa with clindamycin. Int. J. Dermatol. (1983) 22(5):325-328.
13. MORTIMER PS, DAWBER RP, GALES MA, MOORE RA: A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br. J. Dermatol. (1986) 115(3):263-268.
14. STELLON AJ, WAKELING M: Hidradenitis suppurativa associated with use of oral contraceptives. Br. Med. J. (1989) 298(6665):28-29.
15. FARRELL AM, RANDALL VA, VAFAEE T, DAWBER RP: Finasteride as a therapy for hidradenitis suppurativa. Br. J. Dermatol. (1999) 141(6):1138-1139.
16. GOLDSMITH PC, DOWD PM: Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J. R. Soc. Med. (1993) 86(12):729-730.
17. CAMISA C, SEXTON C, FRIEDMAN C: Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report. J. Reprod. Med. (1989) 34(8):543-546.
18. HOLST LARSEN T, JEMEC GBE: Acne: comparing hormonal approaches to antibiotics and isotretinoin. Expert Opin. Pharmacother. (2003) 4:1097-1103.
19. BOER J, VAN GEMERT MJ: Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J. Am. Acad. Dermatol. (1999) 40(1):73-76.
20. FEARFIELD LA, STAUGHTON RC: Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. Clin. Exp. Dermatol. (1999) 24(3):189-192.
21. CHOW ET, MORTIMER PS: Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br. J. Dermatol. (1992) 126(4):415.
22. SCHEMAN AJ: Nodulocystic acne and idradenitis suppurativa treated with acitretin: a case report. Cutis (2002) 69(4):287-288.
23. BUCKLEY DA, ROGERS S: Cyclosporin-responsive hidradenitis suppurativa. J. R. Soc. Med. (1995) 88(5):289P-290P.
24. HOFER T, ITIN PH: [Acne inversa: a dapsone-sensitive dermatosis]. Hautarzt (2001) 52(10 Pt 2):989-992.
25. JEMEC GBE: Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin. Exp. Dermatol. (2002) 27(6):528-529.
26. MARTINEZ F, NOS P, BENLLOCH S, PONCE J: Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm. Bowel Dis. (2001) 7(4):323-326.
27. SULLIVAN TP, NWLSH E, KERDEL FA, BURDICK AE, KIRSNER RS: Infliximab for hidradenitis suppurativa. Br. J. Dermatol. (2003) 149(5):1046-1049.
28. JURGENSMEYER JC, FLEISCHER A: Clinical improvement of refractory hidradenitis suppurativa with etanercept (Poster 58) . J. Am. Acad. Dermatol. (2004) 50(Suppl. 3):15.